Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endocrinology, Diabetes and Metabolism Case Reports is Scopus-indexed (Q3, CiteScore 1.5), WoS ESCI, DOAJ. Published by BioScientifica Ltd..
Checked against the index lists dated .
ISSN 2052-0573Verify ISSN ↗
Publisher: BioScientifica Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 117 / 179 | 34th | Q3 |
| Endocrinology, Diabetes and Metabolism | 192 / 250 | 23rd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present (also 2014–2016), best quartile Q3, CiteScore 1.5.
Endocrinology, Diabetes and Metabolism Case Reports is Q3 in Internal Medicine (rank 117 of 179) and Q4 in Endocrinology, Diabetes and Metabolism (rank 192 of 250), by CiteScore 2025.
Endocrinology, Diabetes and Metabolism Case Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.5, which places it in quartile Q3 at the 34th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.306, quartile Q3, with an H-index of 19.
The publisher lists an article processing charge of about US$612 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Endocrinology, Diabetes and Metabolism Case Reports is published by BioScientifica Ltd. Its ISSN is 2052-0573.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Endocrinology, Diabetes and Metabolism Case Reports has an h-index of 31 and a 2-year mean of 0.83 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #112 of 172 Scopus journals in Internal Medicine.
Endocrinology, Diabetes and Metabolism Case Reports published 84 papers in 2025; its busiest recent year was 2021 with 117. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 76 research articles (2025–2026), authors are most often from Japan (18.4%), United Kingdom (9.9%) and United States (9.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.